Kintara Therapeutics Inc (KTRA)

[Mr. Zen]

So, What is the friggin float here?

Through the date hereof (12/18), we have sold an aggregate of 5,537,589 shares of Common Stock

The Prospectus Supplement relates to the offering by the Company of up to $8,700,000 in shares of the common stock of the Company, par value $0.001 (the “Shares”), covered by the Registration Statement. The Shares are being offered and sold by A.G.P./Alliance Global Partners as sales agent (the “Sales Agent”) pursuant to the Sales Agreement between the Company and the Sales Agent dated September 19, 2023 (the “Sales Agreement”).
Number of shares of common stock outstanding as of November 13, 2023 was 3,387,808.